HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markedly elevated serum preoperative thyroglobulin predicts radioiodine-refractory thyroid cancer.

AbstractBACKGROUND:
Repeated radiotherapy brings limited benefits and significant side effects for differentiated thyroid cancer patients (DTC) with radioiodine refractory (RAIR). However, the prognostic role of preoperative thyroglobulin (pre-Tg) in predicting RAIR is unclear.
METHODS:
In the present study, data were retrospectively reviewed from 5173 patients who underwent radiotherapy in the Jiangyuan Hospital from January 2006 to December 2020.
RESULTS:
A total of 1,102 patients with or without repeated radiotherapy were compared (repeated vs. single radiotherapy; n = 199 vs. n = 903). Pre-Tg was significantly elevated in patients with repeated radiotherapy. After the classification of RAIR (non-RAIR, n = 786 vs. RAIR, n = 90), elevated pre-Tg was also correlated with RAIR after univariate and multivariate analyses. According to the receiver operating characteristic curve analysis, elevated pre-Tg well predicted RAIR (AUC = 0.76, CI: 0.71-0.82, p < 0.0001). To control the selection bias, the propensity score matching was used. Pre-Tg level was found to be an independent predictor of RAIR (p < 0.001, HR = 7.25, CI: 2.55-20.62).
CONCLUSION:
Our results indicate that markedly elevated pre-Tg level can be served as an independent predictor of RAIR-DTC, which can guide a more precise treatment strategy and/or an active surveillance during surgery and follow-ups.
AuthorsXian Cheng, Shichen Xu, Yun Zhu, Jing Wu, Jiandong Bao, Huixin Yu, Li Zhang
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 52 Issue 4 Pg. e13721 (Apr 2022) ISSN: 1365-2362 [Electronic] England
PMID34855206 (Publication Type: Journal Article)
Copyright© 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Chemical References
  • Iodine Radioisotopes
  • Thyroglobulin
Topics
  • Female
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Preoperative Period
  • Retrospective Studies
  • Thyroglobulin (blood)
  • Thyroid Neoplasms (blood, radiotherapy)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: